AstraZeneca in $1.15B Deal for Pearl Therapeutics

June 10 (Bloomberg) -- Bloomberg's Anna Edwards reports that AstraZeneca has agreed to a $1.15 billion deal to buy Pearl Therapeutics, a maker of therapies for respiratory disease. She speaks on Bloomberg Television's "Countdown."
IMF Says Dollar Strength Is a Risk to Asia
55:06 - Higher U.S. interest rates and a strengthening dollar will likely lead to a tightening of domestic financial conditions in the Asia Pacific region, according to the IMF's Asia Pacific Regional Economic Outlook report. Bloomberg's Haslinda Amin has more on "Trending Business." (Source: Bloomberg)
  • Is China Readying a Fiscal Stimulus Package?
  • 'Risk-Reward' Positive in China Over Long Term: Fenton
  • Banks Cut Pound Wagers Amid Election